These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 23168983

  • 21. Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
    Freiberger V, Amann K, Heemann U, Frank H.
    Transpl Int; 2009 Nov; 22(11):1110-3. PubMed ID: 19497068
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Is therapy of people with chronic kidney disease ONTARGET?
    Mann JF, Tobe S, Teo KK, Yusuf S.
    Nephrol Dial Transplant; 2010 Jan; 25(1):42-4. PubMed ID: 19854846
    [No Abstract] [Full Text] [Related]

  • 24. In brief: aliskiren trial terminated.
    Med Lett Drugs Ther; 2012 Jan 23; 54(1382):5. PubMed ID: 22267213
    [No Abstract] [Full Text] [Related]

  • 25. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
    Ram CV.
    Future Cardiol; 2009 Sep 23; 5(5):453-65. PubMed ID: 19715410
    [Abstract] [Full Text] [Related]

  • 26. [Angio-oedema and medication that interferes with the renin-angiotensin-aldosterone system--a systematic review].
    Suhrs HE, Ibsen H.
    Ugeskr Laeger; 2012 Mar 12; 174(11):724-9. PubMed ID: 22409895
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.
    Sharma A, Baliga V, TRIUMPH Study Group.
    J Indian Med Assoc; 2008 Mar 12; 106(3):191-4, 196. PubMed ID: 18712142
    [Abstract] [Full Text] [Related]

  • 28. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.
    Makani H, Bangalore S, Romero J, Wever-Pinzon O, Messerli FH.
    Am J Med; 2011 Feb 12; 124(2):128-35. PubMed ID: 21295192
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [spACE, the last frontier? Renin inhibition in hypertension].
    Villa L.
    G Ital Nefrol; 2008 Feb 12; 25(3):274. PubMed ID: 18473295
    [No Abstract] [Full Text] [Related]

  • 31. Renin inhibition: the holy grail of renin-angiotensin system blockade?
    McInnes GT.
    J Hum Hypertens; 2007 Oct 12; 21(10):766-9. PubMed ID: 17541389
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Renin-angiotensin system blocking drugs.
    Robles NR, Cerezo I, Hernandez-Gallego R.
    J Cardiovasc Pharmacol Ther; 2014 Jan 12; 19(1):14-33. PubMed ID: 24038019
    [Abstract] [Full Text] [Related]

  • 38. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
    Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, Commerford P, Dyal L, Schumacher H, Pogue J, Paolasso E, Holwerda N, Chazova I, Binbrek A, Young J, Yusuf S, ONTARGET and TRANSCEND Investigators.
    Lancet Neurol; 2011 Jan 12; 10(1):43-53. PubMed ID: 20980201
    [Abstract] [Full Text] [Related]

  • 39. Early and effective treatment of hypertension: ONTARGET provides some answers.
    Cardiovasc J Afr; 2009 Jan 12; 20(5):323. PubMed ID: 19907811
    [No Abstract] [Full Text] [Related]

  • 40. [Therapy of hypertension with expanded outlook. Constant pressure decline and organ protection].
    MMW Fortschr Med; 2007 Dec 06; 149(49-50):52-3. PubMed ID: 18236984
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.